Anaerobiospirillum
Anaerobiospirillum is a genus of bacteria that is part of the Spirillaceae family. This genus is characterized by its anaerobic nature, meaning it thrives in environments that lack oxygen. The bacteria are rod-shaped and have a unique spiral structure, which is a defining characteristic of the Spirillaceae family.
Characteristics[edit]
Anaerobiospirillum bacteria are Gram-negative, meaning they do not retain the violet Gram stain used in Gram staining, a method of differentiating bacterial species. These bacteria are also motile, possessing the ability to move independently using flagella.
Species[edit]
There are two recognized species within the Anaerobiospirillum genus: Anaerobiospirillum succiniciproducens and Anaerobiospirillum thomasii. Both species are known to be pathogenic in humans and animals, causing a variety of gastrointestinal diseases.
Anaerobiospirillum succiniciproducens[edit]
Anaerobiospirillum succiniciproducens is the most commonly identified species in human infections. It is known to cause bacteremia and septicemia, serious infections that can lead to sepsis if not treated promptly.
Anaerobiospirillum thomasii[edit]
Anaerobiospirillum thomasii is less commonly associated with human disease, but it has been identified in cases of diarrhea in dogs.
Pathogenesis[edit]
Anaerobiospirillum infections are typically associated with gastrointestinal disease. The bacteria can cause a range of symptoms, including diarrhea, abdominal pain, and fever. In severe cases, the bacteria can enter the bloodstream, leading to bacteremia or septicemia.
Treatment[edit]
Treatment for Anaerobiospirillum infections typically involves antibiotics. The bacteria are generally sensitive to a range of antibiotics, including penicillin, ampicillin, and cephalosporins.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
